Climb Bio, Inc. (CLYM) Form 10-Q Quarterly Reports
Climb Bio, Inc. (CLYM) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CLYM
CIK: 1768446
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerMegan King
Audit LocationSeattle, Washington, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-30 | 2026-09-28 | 4 Filing | 0001231919-26-001416 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-15 | 4 | 0001193125-26-394357 | View SEC Doc Filr Page |
| 144 | 2026-09-15 | — | 144 Filing | 0001950047-26-009491 | View SEC Doc Filr Page |
| 8-K | 2026-09-03 | 2026-09-03 | 8-K | 0001193125-26-381060 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001687078-26-000018 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-13 | 8-K | 0001193125-26-350596 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001193125-26-336774 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001193125-26-336762 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-08 | — | SCHEDULE 13G Filing | 0000315066-26-001452 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-07 | — | SCHEDULE 13D/A Filing | 0001346824-26-000189 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-29 | 4 Filing | 0001231919-26-000722 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-29 | 4 | 0001193125-26-292640 | View SEC Doc Filr Page |
| 3 | 2026-07-01 | 2026-06-29 | 3 | 0001193125-26-292617 | View SEC Doc Filr Page |
| 8-K | 2026-07-01 | 2026-06-29 | 8-K | 0001193125-26-292567 | View SEC Doc Filr Page |
| 4 | 2026-06-30 | 2026-06-27 | 4 | 0001193125-26-291131 | View SEC Doc Filr Page |
| 144 | 2026-06-30 | — | 144 Filing | 0001193125-26-291127 | View SEC Doc Filr Page |
| 8-K | 2026-06-12 | 2026-06-11 | 8-K | 0001193125-26-269567 | View SEC Doc Filr Page |
| 424B5 | 2026-06-12 | — | 424B5 | 0001193125-26-269510 | View SEC Doc Filr Page |
| 8-K | 2026-06-11 | 2026-06-11 | 8-K | 0001193125-26-266688 | View SEC Doc Filr Page |
| EFFECT | 2026-06-09 | — | EFFECT Filing | 9999999995-26-001931 | View SEC Doc Filr Page |
| 424B3 | 2026-06-09 | — | 424B3 | 0001193125-26-263813 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-05 | 4 Filing | 0001231919-26-000610 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-05 | 4 | 0001193125-26-262292 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-05 | 4 | 0001193125-26-262290 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-05 | 4 | 0001193125-26-262287 | View SEC Doc Filr Page |